References

Chemotherapy induced gastrointestinal toxicities

10.1016/bs.acr.2022.02.007 · 2022 · External reference

Para-probiotics as novel anti-inflammatory agents: insight into health benefits and therapeutic applications

10.2174/0113816128411949250909113034 · 2026 · External reference

Instrumental variable methods for causal inference

10.1002/sim.6128 · 2014 · External reference

Hypoglycemic effect of the polysaccharides from Astragalus membranaceus on type 2 diabetic mice based on the “gut microbiota–mucosal barrier

10.1039/d2fo02300h · 2022 · External reference

Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy

10.1186/s12885-020-6654-5 · 2020 · External reference

Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: the impact of the gut microbiota

10.1002/ijc.32942 · 2020 · External reference

Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant

10.1056/nejmoa1910437 · 2019 · External reference

Gut microbiota-derived isovaleric acid alleviates atrial fibrillation by suppressing GSDME-dependent pyroptosis

10.1016/j.cmet.2025.12.017 · 2026 · External reference

Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease

10.1038/s41577-023-00874-w · 2023 · External reference

Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil

10.1016/j.bjid.2023.102745 · 2023 · External reference

The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: a double-blind randomized clinical trial

10.1002/pbc.30328 · 2023 · External reference

Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia

10.1097/inf.0000000000000591 · 2015 · External reference

Fecal microbiota transplantation promotes gut microbiome recovery in pediatric hematopoietic stem cell transplant recipients

2026 · External reference

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

10.1038/nature12721 · 2013 · External reference

Microbiota influences on hematopoiesis and blood cancers: new horizons?

10.1158/2643-3230.bcd-22-0172 · 2023 · External reference

The potential of the gut microbiota and butyrate to enhance CAR T-cell therapy in non-Hodgkin lymphoma

10.1158/1078-0432.ccr-25-1676 · 2026 · External reference

Lactobacillus bloodstream infections genetically related to probiotic use in pediatric hematopoietic cell transplant patients

10.1017/ice.2021.515 · 2023 · External reference

A causal mechanism for childhood acute lymphoblastic leukaemia

10.1038/s41568-018-0015-6 · 2018 · External reference

A gut microbial signature for combination immune checkpoint blockade across cancer types

10.1038/s41591-024-02823-z · 2024 · External reference

Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward

10.1080/19490976.2023.2229567 · 2023 · External reference

The role of butyrate in surgical and oncological outcomes in colorectal cancer

10.1152/ajpgi.00316.2020 · 2021 · External reference

Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia

10.1093/cid/ciy153 · 2018 · External reference

Intestinal barrier functions in hematologic and oncologic diseases

10.1186/s12967-023-04091-w · 2023 · External reference

Treatment of pediatric acute lymphoblastic leukemia: a historical perspective

10.3390/cancers16040723 · 2024 · External reference

Microbiome-based modeling of CAR-T therapy response in lymphoma: insights from shotgun metagenomics sequencing

10.1111/ejh.70121 · 2026 · External reference

Gut microbiome and nutrition-related predictors of response to immunotherapy in cancer: making sense of the puzzle

10.1038/s44276-023-00008-8 · 2023 · External reference

12R-HETE acts as an endogenous ligand for Nur77 in the intestines and regulates NKp46+ ILC3 development

10.1126/sciadv.adz8405 · 2026 · External reference

Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia

10.1002/cncr.28688 · 2014 · External reference

Pediatric acute lymphoblastic leukemia

10.3324/haematol.2020.247031 · 2020 · External reference

Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation

10.1186/s40168-019-0745-z · 2019 · External reference

JBI Manual for Evidence Synthesis

2024 · External reference

Metabolic tug-of-war: microbial metabolism shapes colonization resistance against enteric pathogens

10.1016/j.chembiol.2024.12.005 · 2025 · External reference

Significance of Th17 and Treg in treatment efficacy and outcome in pediatric acute lymphoblastic leukemia

10.3390/ijms241512323 · 2023 · External reference

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

10.1038/s41575-019-0258-z · 2020 · External reference

Impact of antibiotics on off-target infant gut microbiota and resistance genes in cohort studies

10.1038/s41390-022-02104-w · 2022 · External reference

Roles of secretory immunoglobulin A in host-microbiota interactions in the gut ecosystem

10.3389/fmicb.2022.880484 · 2022 · External reference

Extremophyte-derived exosome-like nanovesicles remodel intestinal barrier dysfunction by multi-dimensional intervention: physical barrier repair with immune homeostasis and microbiome regulation

2026 · External reference

A decrease in Flavonifractor plautii and its product, phytosphingosine, predisposes individuals with phlegm-dampness constitution to metabolic disorders

10.1038/s41421-025-00789-x · 2025 · External reference

Study on the effect of molecular weight on the gut microbiota fermentation properties of blackberry polysaccharides in vitro

10.1021/acs.jafc.2c03091 · 2022 · External reference

Gut microbiome-targeted therapeutics for chronic kidney disease: comparative efficacy of probiotic and microbial preparations

10.1007/s10787-025-02044-x · 2025 · External reference

Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome

10.1038/s41588-021-00968-y · 2022 · External reference

Pediatric acute lymphoblastic leukemia patients exhibit distinctive alterations in the gut microbiota

10.3389/fcimb.2020.558799 · 2020 · External reference

Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage

10.1200/go.21.00266 · 2022 · External reference

Microbiota predict infections and acute graft-versus-host disease after pediatric allogeneic hematopoietic stem cell transplantation

10.1093/infdis/jiad190 · 2023 · External reference

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

10.1182/blood.2023020026 · 2023 · External reference

Recent advances in lipopolysaccharide recognition systems

10.3390/ijms21020379 · 2020 · External reference

Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis

10.1080/19490976.2020.1870402 · 2021 · External reference

Fecal microbiota transplantation donor screening updates and research gaps for solid organ transplant recipients

10.1128/jcm.00161-21 · 2022 · External reference

Unresolved reference

External reference

Distinct effects of a dairy probiotic drink and physical exercise on gut microbiota in pediatric acute lymphoblastic leukemia patients in remission: a randomized clinical trial

10.3389/fmicb.2026.1791192 · 2026 · External reference

The microbiome in childhood acute lymphoblastic leukemia

10.3390/cancers13194947 · 2021 · External reference

Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer

10.1038/s41523-024-00707-6 · 2024 · External reference

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

10.1136/bmj.n71 · 2021 · External reference

Gut microbiome immaturity and childhood acute lymphoblastic leukaemia

10.1038/s41568-023-00584-4 · 2023 · External reference

Microbial tryptophan catabolites in health and disease

10.1038/s41467-018-05470-4 · 2018 · External reference

Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial

10.1016/j.cmi.2016.11.001 · 2017 · External reference

Relapsed acute lymphoblastic leukemia

10.1007/s12098-023-04635-4 · 2024 · External reference

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

10.1038/s41591-022-01702-9 · 2022 · External reference

Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia

10.1182/bloodadvances.2024013986 · 2025 · External reference

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

10.1038/s41591-023-02234-6 · 2023 · External reference

Temporal development of the gut microbiome in early childhood from the TEDDY study

10.1038/s41586-018-0617-x · 2018 · External reference

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity

10.3389/fimmu.2023.1127743 · 2023 · External reference

The gut connection: a narrative review on the in-depth analysis of gut microbiota and metabolites in depression

10.2174/0127724328332998250118182255 · 2026 · External reference

Effects of high-inorganic-phosphorus diet on intestinal mucosal injury and immune alteration in mice

10.3390/nu18101590 · 2026 · External reference

The Integrative Human Microbiome Project

10.1038/s41586-019-1238-8 · 2019 · External reference

Striking a balance: how the gut microbiome shapes the fate of intestinal CD4+ T cells

10.1093/discim/kyaf020 · 2026 · External reference

10.1186/s12885-022-09522-3

10.1186/s12885-022-09522-3 · 2022 · External reference

ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study

10.1038/s41416-025-02958-x · 2025 · External reference

Infectious complications during early treatment of childhood acute lymphoblastic leukemia-a comparison between the ALLTogether and NOPHO ALL-2008 protocols

10.1002/pbc.32120 · 2026 · External reference

Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut

10.1086/599346 · 2009 · External reference

Early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia in Denmark: an open-label, randomised controlled trial

10.1016/s2352-4642(26)00039-8 · 2026 · External reference

Reading and conducting instrumental variable studies: guide, glossary, and checklist

10.1136/bmj-2023-078093 · 2024 · External reference

Microbial metagenomic shifts in children with acute lymphoblastic leukaemia during induction therapy and predictive biomarkers for infection

10.1186/s12941-024-00717-z · 2024 · External reference

Intestinal mucositis, systemic inflammation and bloodstream infections following high-dose methotrexate treatment in childhood acute lymphoblastic leukaemia: comparison between the NOPHO ALL 2008 protocol and the ALLTogether1 protocol

10.1002/ijc.35136 · 2025 · External reference

Interactions between gut microbiota and acute childhood leukemia

10.3389/fmicb.2019.01300 · 2019 · External reference

Next-generation sequencing: insights to advance clinical investigations of the microbiome

10.1172/jci154944 · 2022 · External reference

The role of inflammasomes in human diseases and their potential as therapeutic targets

10.1038/s41392-023-01687-y · 2024 · External reference

Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia

10.1080/08880018.2016.1276235 · 2017 · External reference

Remodeling the gut ecosystem and its mechanism: natural products in the treatment of ulcerative colitis via regulating gut microbiota and metabolites

10.1016/j.intimp.2026.116378 · 2026 · External reference

Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: a review

10.1016/j.biopha.2023.114985 · 2023 · External reference

NLRP3 inflammasome promotes the progression of acute myeloid leukemia via IL-1β pathway

2021 · External reference